ALSO READMarksans Pharma corrects on profit booking Marksans Pharma gets ANDA approval for Loratadine Liquid Capsules 10mg Marksans Pharma gets USFDA clearance for allergy drug Marksans Pharma gets ANDA approval for Metformin Hydrochloride ER Tablets Marksans Pharma gets USFDA nod for diabetes treatment tablets
From USFDAMarksans Pharma announced that USFDA has granted approval for an Abbreviated New Drug Application (ANDA) for Paricalcitol Capsules 1mcg, 2 mcg and 4 mcg.
Paricalcitol Capsules 1mcg, 2 mcg and 4 mcg are therapeutically equivalent to the reference listed drug Zemplar Capsules 1 mcg, 2 mcg and 4 mcg of Abbvie Inc.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)